Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
54
BLTE Quote, Financials, Valuation and Earnings
Last price:
$154.94
Seasonality move
:
-4.96%
Day range:
$148.10 - $157.48
52-week range:
$49.00 - $170.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
21.23x
Volume:
159.5K
Avg. volume:
250.9K
1-year change:
192.44%
Market cap:
$5.8B
Revenue:
--
EPS (TTM):
-$1.92
Earnings Data
Next earnings date for BLTE
Mar 10
2026
Most recent earnings per share
-$0.65
Missed by $0.16
(Nov 10/2025)
Consensus Estimate
-$0.49
(Nov 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BLTE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | -- | -- | -- | -$0.63 | -- |
| 03/10/2026 | Q4 | -- | -- | -- | -$0.52 | -- |
| 11/10/2025 | Q3 | -- | -- | -$0.65 | -$0.49 | -$0.16 |
| 08/11/2025 | Q2 | -- | -- | -$0.50 | -$0.42 | -$0.08 |
| 05/12/2025 | Q1 | -- | -- | -$0.45 | -$0.37 | -$0.08 |
| 03/17/2025 | Q4 | -- | -- | -$0.32 | -$0.31 | -$0.01 |
| 11/12/2024 | Q3 | -- | -- | -$0.28 | -$0.30 | $0.02 |
| 08/12/2024 | Q2 | -- | -- | -$0.31 | -$0.26 | -$0.05 |
| 05/14/2024 | Q1 | -- | -- | -$0.27 | -$0.29 | $0.02 |
| 03/12/2024 | Q4 | -- | -- | -$0.25 | -$0.30 | $0.05 |
| 11/14/2023 | Q3 | -- | -- | -$0.40 | -- | -- |
| 08/09/2023 | Q2 | -- | -- | -$0.26 | -- | -- |
| 05/10/2023 | Q1 | -- | -- | -$0.33 | -- | -- |
| 03/31/2023 | Q4 | -- | -- | -$0.31 | -- | -- |
| 12/15/2022 | Q3 | -- | -- | -$0.10 | -- | -- |
| 08/10/2022 | Q2 | -- | -- | -$0.12 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.04 | -- | -- |
Belite Bio, Inc. Earnings Questions
-
How Much did Belite Bio, Inc. Generate in Revenue Last Quarter?
Belite Bio, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Belite Bio, Inc. Beat Earnings Last Quarter?
Belite Bio, Inc. announced earnings per share of -$0.65 which represents a miss of analyst forecast a -$0.49 per share.
-
Is Belite Bio, Inc. Profitable?
Belite Bio, Inc. reported -$347K that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for Belite Bio, Inc. EPS Next Year?
Belite Bio, Inc.'s earnings are forecast to decrease from -$1.18 per share to -$0.86 per share next year representing a decrease of -27.62%.
-
When is Belite Bio, Inc.'s Earnings Date?
Belite Bio, Inc.'s next earnings date is March 10, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
